Schizophrenia News and Research

Latest Schizophrenia News and Research

Longer looks: Fight against meth labs faces drug makers' opposition

Every week reporter Ankita Rao selects interesting reading from around the Web.

16 Aug 2013

Flexible hubs coordinate brain’s responses to novel cognitive challenges

One thing that sets humans apart from other animals is our ability to intelligently and rapidly adapt to a wide variety of new challenges - using skills learned in much different contexts to inform and guide the handling of any new task at hand.

13 Aug 2013

Emory’s Yerkes Research Center receives $9.5M grant to establish research center to study oxytocin

The Yerkes National Primate Research Center, Emory University, has received a five-year, $9.5 million grant from the National Institute of Mental Health (NIMH) to establish a Silvio O. Conte Center in Neuroscience Research to study oxytocin, a brain chemical known for forming bonds between mother and baby.

13 Aug 2013

Omeros announces financial results for second quarter of 2013

Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.

12 Aug 2013

Study shows schizophrenia, bipolar disorder share the most common genetic variation

The largest genome-wide study of its kind has determined how much five major mental illnesses are traceable to the same common inherited genetic variations. Researchers funded in part by the National Institutes of Health found that the overlap was highest between schizophrenia and bipolar disorder; moderate for bipolar disorder and depression and for ADHD and depression; and low between schizophrenia and autism.

12 Aug 2013

The Estate of Charles Meixner awards $3M to Autism Speaks to discover treatments for ASD

Autism Speaks, the world's leading autism science and advocacy organization, today announced that the estate of Charles Meixner has donated $3 million to support Autism Speaks' Translational Research Initiative in the hopes of accelerating the discovery of treatments for autism spectrum disorder (ASD).

12 Aug 2013

Scientist receives prestigious USU Medal and 'Order of Military Medical Merit' awards from IRSF

The International Rett Syndrome Foundation (IRSF), the world's largest and most comprehensive not-for-profit organization that funds novel research for treatments and a cure for Rett syndrome, has announced that Steven G. Kaminsky, Ph.D., received two incredibly prestigious awards at the 2013 Annual Family Conference in Midway, Utah this past June.

8 Aug 2013

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

8 Aug 2013

Scientists identify important molecular signal that guides development of brain

Scientists at The Scripps Research Institute (TSRI) have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex.

8 Aug 2013

Researchers identify specific genetic mutations that contribute to disorders of brain development

A collaborative team of researchers including scientists from UCLA has uncovered evidence that a specific genetic alteration appears to contribute to disorders of brain development, including schizophrenia. They also found that schizophrenia shares a common biological pathway with Fragile X mental retardation syndrome, a disorder associated with both intellectual impairment and autism.

7 Aug 2013

Targacept reports net loss of $12.4 million for Q2 2013

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today reported its financial results for the second quarter and six months ended June 30, 2013.

6 Aug 2013

BioLineRx reports positive results from pre-clinical trials with RHB-104 for treatment of thrombocytopenia

BioLineRx, a biopharmaceutical development company, announced today that BL-8040 has been shown in pre-clinical trials to be effective for the treatment of thrombocytopenia, or reduced platelet production.

5 Aug 2013

Disruption to TOP3B gene increases susceptibility to schizophrenia and a learning disorder

A team of researchers have shown that schizophrenia and a disorder associated with autism and learning difficulties share a common biological pathway. This is one of the first times that researchers have uncovered genetic evidence for the underlying causes of schizophrenia.

5 Aug 2013

Research roundup: Making sense (or not) of health insurance; what a full Medicaid expansion could look like; recession and coverage

Each week, KHN reporter Alvin Tran compiles a selection of recently released health policy studies and briefs.

3 Aug 2013

Study proposes novel approach for understanding how genome affects biology of the human body

Recent technological developments in genomics have revealed a large number of genetic influences on common complex diseases, such as diabetes, asthma, cancer or schizophrenia. However, discovering a genetic variant predisposing to a disease is only a first step. To apply this knowledge towards prevention or cure, including tailoring treatment to the patient’s genetic profile –also known as personalized medicine – we need to know how this genetic variant affects health.

1 Aug 2013

Montreal scientists develop novel approach for scanning entire genome

Recent technological developments in genomics have revealed a large number of genetic influences on common complex diseases, such as diabetes, asthma, cancer or schizophrenia. However, discovering a genetic variant predisposing to a disease is only a first step. To apply this knowledge towards prevention or cure, including tailoring treatment to the patient's genetic profile -also known as personalized medicine - we need to know how this genetic variant affects health.

1 Aug 2013

Study: Full Body Illusions can be accompanied by changes in body temperature

Researchers from the Center for Neuroprosthetics at the Swiss Federal Institute of Technology (EPFL), Switzerland, show that people can be "tricked" into feeling that an image of a human figure -- an "avatar" -- is their own body. The study is published in the open-access journal Frontiers in Behavioral Neuroscience.

31 Jul 2013

Schizophrenia News and Research

Latest Schizophrenia News and Research

Longer looks: Fight against meth labs faces drug makers' opposition

Flexible hubs coordinate brain’s responses to novel cognitive challenges

Emory’s Yerkes Research Center receives $9.5M grant to establish research center to study oxytocin

Omeros announces financial results for second quarter of 2013

Study shows schizophrenia, bipolar disorder share the most common genetic variation

The Estate of Charles Meixner awards $3M to Autism Speaks to discover treatments for ASD

Scientist receives prestigious USU Medal and 'Order of Military Medical Merit' awards from IRSF

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists identify important molecular signal that guides development of brain

Researchers identify specific genetic mutations that contribute to disorders of brain development

Targacept reports net loss of $12.4 million for Q2 2013

BioLineRx reports positive results from pre-clinical trials with RHB-104 for treatment of thrombocytopenia

Disruption to TOP3B gene increases susceptibility to schizophrenia and a learning disorder

Research roundup: Making sense (or not) of health insurance; what a full Medicaid expansion could look like; recession and coverage

Study proposes novel approach for understanding how genome affects biology of the human body

Montreal scientists develop novel approach for scanning entire genome

Study: Full Body Illusions can be accompanied by changes in body temperature

Naurex receives new U.S. patent for its lead compound, GLYX-13

Researcher discovers potential explanation for shizophrenia symptoms

Some warn of 'overwhelming' mental illness care cost without new research investment

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Schizophrenia News and Research

Latest Schizophrenia News and Research

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in